Related Experiment Video
Updated: Apr 27, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Development and application of chronic disease risk prediction models
Sun Min Oh1, Katherine M Stefani2, Hyeon Chang Kim3
1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea. ; Medical Affairs, Novartis Korea Oncology, Seoul, Korea.
Chronic disease prediction models aid clinical decisions by estimating individual risk. This review covers model development and evaluation methods, focusing on their current use in Korea.
Area of Science:
- Epidemiology
- Biostatistics
- Public Health
Background:
- Non-communicable chronic diseases (NCDs) are leading causes of death globally.
- Many NCDs are preventable through risk factor management, but individual prevention efficacy remains suboptimal.
- Chronic disease prediction models offer a tool for personalized risk assessment to guide clinical decisions.
Purpose of the Study:
- To review methodologies for developing and evaluating chronic disease prediction models.
- To discuss the current status and clinical utility of these models in the Korean population.
Main Methods:
- Review of methodologies for chronic disease prediction model development.
- Evaluation of statistical approaches used in prediction modeling.
- Analysis of existing chronic disease prediction tools and their application.
Main Results:
- Numerous prediction models exist, particularly for cardiovascular diseases and cancers, with some integrated into international guidelines.
- The clinical utility of available chronic disease prediction tools in Korea is currently limited.
- Methodologies for model development and evaluation are well-established but require adaptation for specific populations.
Conclusions:
- Effective chronic disease prediction models are crucial for personalized prevention and treatment strategies.
- Further development and validation of prediction models tailored to the Korean population are needed to enhance clinical utility.
- Standardized methodologies for model development and evaluation are essential for reliable risk prediction.
Related Concept Videos
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Coronary Artery Disease I: Introduction
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Mechanistic Models: Compartment Models in Individual and Population Analysis
